CancerCare Manitoba ( Site 0101)

Winnipeg, Manitoba R3E 0V9

0 studies enrolling now · 1 studies all time

What they study most

Hodgkin Disease, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin

Studies at this site

• Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) — Stopped early